STOK — Stoke Therapeutics Inc. price, chart and key statistics

Price data

Price

$24.17

YTD price return

-23.85%

YTD total return

-23.85%

Next earnings

Nov 3, 2026

Market cap

1.6B2019-09 703.4M2026-10 1.6B+122.0% over the window

Enterprise value

1.5B

Shares outstanding

64.5M2018-12 727.4K2026-06 64.5M+8770.6% over the window

52W low

$20.32

52W high

$40.22

From 52W high

-39.91%

From 52W low

+18.95%

52W range

19%

Volume

Rel volume

0.96×

30D volume

913.5K

30D $ vol

24M

Fundamentals

Sales (ttm)

27.6M2022-12 12.4M2026-06 27.6M+122.4% over the window

Sales/share

$0.432022-12 $0.282026-06 $0.43+52.2% over the window

EPS (ttm)

-$3.422021-06 -$1.832026-06 -$3.42+87.2% over the window

FCF (ttm)

-180.7M2018-12 -11.9M2026-06 -180.7M+1418.4% over the window

FCF/share

-$2.802018-12 -$16.362026-06 -$2.80-82.9% over the window

Book value/share

$5.362018-12 $144.442026-06 $5.36-96.3% over the window

Net margin

-753.60%2022-12 -814.7%2026-06 -753.6%-7.5% over the window

ROE

-60.17%2018-12 -11.9%2026-06 -60.2%+404.9% over the window

ROA

-52.77%2018-12 -11.6%2026-06 -52.8%+353.2% over the window

Current ratio

7.692018-12 43.032026-06 7.69-82.1% over the window

Growth (CAGR, ttm) · 10Y

Sales

-86.22%2025-06-30 → 2026-06-30199.9M → 27.6M (-86.2% total)+46.10%2023-06-30 → 2026-06-308.8M → 27.6M (+211.9% total)n/an/a

Shares

+17.77%2025-06-30 → 2026-06-3054.8M → 64.5M (+17.8% total)+13.39%2023-06-30 → 2026-06-3044.3M → 64.5M (+45.8% total)+11.92%2021-06-30 → 2026-06-3036.7M → 64.5M (+75.6% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share

-88.30%2025-06-30 → 2026-06-30$3.65 → $0.43 (-88.3% total)+28.85%2023-06-30 → 2026-06-30$0.20 → $0.43 (+114.0% total)n/an/a

Book value/share

-12.40%2025-06-30 → 2026-06-30$6.11 → $5.36 (-12.4% total)+7.61%2023-06-30 → 2026-06-30$4.30 → $5.36 (+24.6% total)-5.06%2021-06-30 → 2026-06-30$6.94 → $5.36 (-22.8% total)n/a

Price

-29.28%2025-10-16 → 2026-10-16$34.17 → $24.17 (-29.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+82.12%2023-10-16 → 2026-10-16$4.00 → $24.17 (+504.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+0.55%2021-10-15 → 2026-10-16$23.52 → $24.17 (+2.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

-29.28%2025-10-16 → 2026-10-16$34.17 → $24.17 (-29.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+82.12%2023-10-16 → 2026-10-16$4.00 → $24.17 (+504.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+0.55%2021-10-15 → 2026-10-16$23.52 → $24.17 (+2.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-7.1×2019-09 -26.602026-10 -7.51-71.8% over the window

Fwd P/E

-7.0×

P/S (ttm)Market cap ÷ TTM revenue.

56.5×2023-03 25.292026-10 56.60+123.8% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

4.5×2019-09 3.012026-10 4.52+50.1% over the window

EV/Sales (ttm)

52.6×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-11.59%2019-12 -3.5%2026-06 -8.6%+144.2% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 64.5M ÷ 54.8M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-17.77%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-17.77%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($622M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-17.77%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.6B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2019-12 0.0%2026-06 0.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.6B). Same caveat as the cash buyback yield.

0.00%2019-12 0.0%2026-06 0.0%

Vs own 10Y history

P/S

79th

P/B

71st